Thyroid gland: Antithyroid therapybest choice of drug and dose

Nature Reviews Endocrinology

Volumn 5, Issue 11, 2009, Pages 592-594

  Franklyn, Jayne A ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; ANTITHYROID AGENT; CARBIMAZOLE; PROPYLTHIOURACIL; THIAMAZOLE; THIONAMIDE; THYROXINE;

AGRANULOCYTOSIS; BLOOD CELL COUNT; BLOOD DYSCRASIA; DRUG CHOICE; DRUG EFFICACY; DRUG MEGADOSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; HEALTH CARE PERSONNEL; HUMAN; HYPERTHYROIDISM; LIVER FAILURE; LIVER TOXICITY; PRESCRIPTION; PRIORITY JOURNAL; PRURITUS; RASH; SHORT SURVEY; THYROID SURGERY; THYROXINE BLOOD LEVEL;

AGRANULOCYTOSIS; ANTITHYROID AGENTS; HUMANS; METHIMAZOLE; THYROID GLAND;

EID: 70350339650     PISSN: 17595029     EISSN: 17595037     Source Type: Journal    
DOI: 10.1038/nrendo.2009.201     Document Type: Short Survey

References (9)

1. Cooper, D. S. Antithyroid drugs. N. Engl. J. Med. 352, 905-917 (2005).
2. Tajiri, J. & noguchi, S. Antithyroid drug-induced agranulocytosis: special reference to normal white blood cell count agranulocytosis. Thyroid 14, 459-462 (2004).
3. Takata, K. et al. Methimazole-induced agranulocytosis in patients with Graves' disease is more frequent with an initial dose of 30 mg daily than with 15 mg daily. Thyroid 19, 559-563 (2009).
4. Pearce, S. H. spontaneous reporting of adverse reactions to carbimazole and propylthiouracil in the UK. Clin. Endocrinol. (Oxf.) 61, 589-594 (2004).
5. Nakamura, H. et al. Comparison of methimazole and propylthiouracil in patients with hyperthyroidism caused by Graves' disease. J. Clin. Endocrinol. Metab. 92, 2157-2162 (2007).
6. Abraham, P., Avenell, A., Park, C. M., Watson, W. A. & Bevan, J. S. A systematic review of drug therapy for Graves' hyperthyroidism. Eur. J. Endocrinol. 153, 489-498 (2005).
7. Kim, H. J. et al. The incidence and clinical characteristics of symptomatic propylthiouracilinduced hepatic injury in patients with hyperthyroidism: A single-center retrospective study. Am. J. Gastroenterol. 96, 165-169 (2001).
8. Cooper, D. S. & Rivkees, S. A. Putting propylthiouracil in perspective. J. Clin. Endocrinol. Metab. 94, 1881-1882 (2009).
9. Bahn, R. S. et al. The Role of Propylthiouracil in the Management of Graves' Disease in Adults: report of a meeting jointly sponsored by the American Thyroid Association and the Food and Drug Administration. Thyroid 19, 673-674 (2009).